The escalating global prevalence of MASLD is concerning, as the disease can progress silently to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC)
Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)
This ensures they remain sterile and the delicate tips are protected from damage
In sports research, its valued for its potential to shorten recovery time after injuries, from sprains to overuse